John Shine

John Shine AO, FAA
Shine, pictured at the Garvan Institute of Medical Research in 2010.
Born	(1946-07-03) 3 July 1946 Brisbane, Queensland
Nationality	Australian
Fields	Biochemistry Molecular biology
Institutions	Garvan Institute of Medical Research UNSW Australia
Alma mater	Australian National University University of California, SF
Known for	Shine-Dalgarno sequence

Professor John Shine AO, FAA (born 3 July 1946) is an Australian biochemist and molecular biologist.^[1] Shine discovered the nucleotide sequence, called the Shine-Dalgarno sequence, necessary for the initiation and termination of protein synthesis.^[2] He directed the Garvan Institute of Medical Research in Sydney between 1990 and 2011.

Background and early career

The brother of scientist, Richard Shine,^[3] John Shine was born in Brisbane in 1946 and completed his university studies at the Australian National University (ANU) in Canberra, graduating with a bachelor of science with honours in 1972 and completing his PhD in 1975. During the course of his studies he discovered the RNA sequence necessary for ribosome binding and the initiation of protein synthesis in the bacterium Escherichia coli. The sequence was named the Shine-Dalgarno sequence. This was a key discovery allowing further development of molecular biology, especially genetic engineering, and was an important discovery towards understanding gene expression and regulation.

Shine undertook post doctoral research at the Department of Biochemistry and Biophysics at the University of California, San Francisco (UCSF), during this period he was the first to clone a human hormone gene and was a central figure in the cloning of the insulin and growth hormone genes. He also determined the first sequence responsible for replication of a cancer causing virus.

Returning to Australia and the Australian National University in 1978, he cloned the human renin gene and cloned the endorphin gene, going on to demonstrate that human hormone genes cloned in bacteria could be expressed in a biologically active form. He also founded the Centre for Recombinant DNA Research at ANU. In 1982 he was awarded that Gottschalk Medal by the Australian Academy of Science.

Shine returned to the United States in 1984, taking a position at UCSF and directing a biotechnology company California Biotechnology Inc.^[1] He was instrumental in the development and growth of the company, now Scios, and subsequently sold to Johnson and Johnson.

He returned to Australia again in 1987 to take a professorship in molecular biology at the UNSW Australia and became the deputy director of the Garvan Institute. He was Chairman of the National Health and Medical Research Council from 2003 - 2006. He is currently a Professor of Medicine and Professor of Molecular Biology at Garvan Institute of Medical Research,^[4] Chairman of CSL Limited, and President of the Board of Museum of Applied Arts and Science ( Powerhouse Museum, Sydney Observatory).

Awards

The Shine Dome of the Australian Academy of Science in Canberra.

In 1994 Shine was elected a Fellow of the Australian Academy of Science. He donated A$1 million to the Academy in 2000 to assist with funding the restoration of the building; subsequently named the Shine Dome in his honour.^[5]

Shine was appointed an Officer of the Order of Australia in 1996 for service to medical research, particularly in the field of molecular biology.^[6] In 2010, Shine was awarded the Prime Minister's Prizes for Science, the nation's highest scientific award.^[7]

References

• Royal Society of New South Wales. 1130th General Monthly Meeting: Humanity's Future - Understanding our Genome, 2004

External links

• Garvan Institute
• Professor John Shine
• Scios